HIV integration site distributions in resting and activated CD4+ T cells infected in culture

Objective:The goal of this study was to investigate whether the location of HIV integration differs in resting versus activated T cells, a feature that could contribute to the formation of latent viral reservoirs via effects on integration targeting. Design:Primary resting or activated CD4+ T cells were infected with purified X4-tropic HIV in the presence and absence of nucleoside triphosphates and genomic locations of integrated provirus determined. Methods:We sequenced and analyzed a total of 2661 HIV integration sites using linker-mediated PCR and 454 sequencing. Integration site data sets were then compared to each other and to computationally generated random distributions. Results:HIV integration was favored in active transcription units in both cell types, but integration sites from activated cells were found more often in genomic regions that were dense in genes, dense in CpG islands, and enriched in G/C bases. Integration sites from activated cells were also more strongly correlated with histone methylation patterns associated with active genes. Conclusion:These data indicate that integration site distributions show modest but significant differences between resting and activated CD4+ T cells, and that integration in resting cells occurs more often in regions that may be suboptimal for proviral gene expression.

[1]  F. Bushman,et al.  Retroviral DNA integration: HIV and the role of LEDGF/p75. , 2006, Trends in genetics : TIG.

[2]  Paul Shinn,et al.  Integration Targeting by Avian Sarcoma-Leukosis Virus and Human Immunodeficiency Virus in the Chicken Genome , 2005, Journal of Virology.

[3]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[4]  J. Griffith,et al.  Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration , 1996, Journal of virology.

[5]  A. Haase,et al.  Determination of simian immunodeficiency virus production by infected activated and resting cells , 2007, AIDS.

[6]  C. June,et al.  Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  F. Bushman,et al.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.

[8]  U. O’Doherty Mechanisms of human immunodeficiency virus‐1 latency , 2005, Transfusion.

[9]  R. Siliciano,et al.  Resting CD4+ T Cells from Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals Carry Integrated HIV-1 Genomes within Actively Transcribed Host Genes , 2004, Journal of Virology.

[10]  R. Siliciano,et al.  Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. , 2008, Cell host & microbe.

[11]  Paul Shinn,et al.  HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  M A Nowak,et al.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Siliciano,et al.  The challenge of viral reservoirs in HIV-1 infection. , 2002, Annual review of medicine.

[14]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.

[15]  A. Engelman,et al.  LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. , 2007, Genes & development.

[16]  C. June,et al.  Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunity. , 2001, The Journal of experimental medicine.

[17]  M. Malim,et al.  Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding , 2000, Journal of Virology.

[18]  Sean D. Taverna,et al.  How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers , 2007, Nature Structural &Molecular Biology.

[19]  Dustin E. Schones,et al.  Dynamic Regulation of Nucleosome Positioning in the Human Genome , 2008, Cell.

[20]  S. Burgess,et al.  Weak Palindromic Consensus Sequences Are a Common Feature Found at the Integration Target Sites of Many Retroviruses , 2005, Journal of Virology.

[21]  F. Bushman,et al.  Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences , 2004, PLoS biology.

[22]  F. Bushman,et al.  Chromosome Structure and Human Immunodeficiency Virus Type 1 cDNA Integration: Centromeric Alphoid Repeats Are a Disfavored Target , 1998, Journal of Virology.

[23]  Frederic D. Bushman,et al.  A quantitative assay for HIV DNA integration in vivo , 2001, Nature Medicine.

[24]  H. Varmus,et al.  Simian virus 40 minichromosomes as targets for retroviral integration in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Dai,et al.  HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration. , 2007, Virology.

[26]  Irene K. Moore,et al.  A genomic code for nucleosome positioning , 2006, Nature.

[27]  Paul Shinn,et al.  Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site Selection , 2006, PLoS pathogens.

[28]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[29]  M. Malim,et al.  A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration , 2002, Journal of Virology.

[30]  F. Bushman,et al.  DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations , 2007, Nucleic acids research.

[31]  John M. Coffin,et al.  Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Richman,et al.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.

[33]  J. Zack,et al.  Immediate Activation Fails To Rescue Efficient Human Immunodeficiency Virus Replication in Quiescent CD4+ T Cells , 2007, Journal of Virology.

[34]  J. Dai,et al.  Human Immunodeficiency Virus Type 1 Can Establish Latent Infection in Resting CD4+ T Cells in the Absence of Activating Stimuli , 2005, Journal of Virology.

[35]  C. June,et al.  Addition of Deoxynucleosides Enhances Human Immunodeficiency Virus Type 1 Integration and 2LTR Formation in Resting CD4+ T Cells , 2007, Journal of Virology.

[36]  F. Bushman,et al.  DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer , 2008, Nucleic acids research.

[37]  F. Bushman,et al.  HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. , 2007, Genome research.

[38]  F. Bushman,et al.  Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor. , 2006, Human gene therapy.

[39]  A. Jordan,et al.  The site of HIV‐1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation , 2001, The EMBO journal.

[40]  F. Bushman,et al.  The influence of DNA and nucleosome structure on integration events directed by HIV integrase. , 1994, The Journal of biological chemistry.

[41]  Paul Shinn,et al.  Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  F. Bushman,et al.  Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Jared E. Toettcher,et al.  Stochastic Gene Expression in a Lentiviral Positive-Feedback Loop: HIV-1 Tat Fluctuations Drive Phenotypic Diversity , 2005, Cell.

[44]  Sridhar Hannenhalli,et al.  Genome-wide analysis of retroviral DNA integration , 2005, Nature Reviews Microbiology.

[45]  F. Bushman,et al.  Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting , 2007, PloS one.

[46]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[47]  Mary K. Lewinski,et al.  Genome-Wide Analysis of Chromosomal Features Repressing Human Immunodeficiency Virus Transcription , 2005, Journal of Virology.

[48]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[49]  Marcela V Maus,et al.  A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes. , 2002, Clinical immunology.

[50]  Tina Lenasi,et al.  Transcriptional interference antagonizes proviral gene expression to promote HIV latency. , 2008, Cell host & microbe.

[51]  R. Siliciano,et al.  Experimental approaches to the study of HIV-1 latency , 2007, Nature Reviews Microbiology.

[52]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[53]  C. June,et al.  Lack of Coreceptor Allows Survival of Chronically Stimulated Double-Negative α/β T Cells , 2001, The Journal of Experimental Medicine.

[54]  Sridhar Hannenhalli,et al.  Selection of Target Sites for Mobile DNA Integration in the Human Genome , 2006, PLoS Comput. Biol..

[55]  Paul Shinn,et al.  A role for LEDGF/p75 in targeting HIV DNA integration , 2005, Nature Medicine.